Paul Allegretti is a Principal Scientist at Eikon Therapeutics, having previously held roles as a Research Scientist at Theravance Biopharma US, Inc. and as a Postdoctoral Fellow at Stanford University School of Medicine. With a PhD in Organic Chemistry from Colorado State University, Paul also has experience as an Instructor at Colorado State University, teaching various chemistry courses.
January 1, 2024 - present
December, 2021